---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-120797"
form_type: "8-K"
ticker: "MNKD"
cik: "0000899460"
company_name: "MANNKIND CORP"
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T07:10:10.333833+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MannKind Chief Medical Officer Burkhard Blank to depart; separation terms include $386K bonus

## Summary
- Burkhard Blank stepped down as CMO and EVP R&D effective May 9, 2025, becoming non-executive employee.
- Last day of employment is August 1, 2025; base salary continued for 13 weeks through Oct 31, 2025.
- One-time special bonus of $386,000 payable in January 2026; COBRA premiums reimbursed until Oct 31.
- Equity awards continue to vest while Blank remains employed.

## SEC filing metadata
- accession: 0001193125-25-120797
- form_type: 8-K
- ticker: MNKD
- cik: 0000899460
- company_name: MANNKIND CORP
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899460/000119312525120797/0001193125-25-120797-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899460/000119312525120797/d915656d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-120797
- JSON: https://secwatch.observer/filing/0001193125-25-120797.json
- Plain text: https://secwatch.observer/filing/0001193125-25-120797.txt

## Source-grounded claims
- claim_id: e212338552
  claim: Burkhard Blank changed role as Chief Medical Officer and Executive Vice President, Research & Development at MANNKIND CORP.
  evidence_excerpt: On May 9, 2025, MannKind Corporation (the “Company”) and Burkhard Blank, Chief Medical Officer and Executive Vice President, Research & Development, mutually agreed that Mr. Blank would step down from his role as an executive officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/899460/000119312525120797/0001193125-25-120797-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.